David Henry's JCSO podcast, January 2016

In his January podcast for The Journal of Community and Supportive Oncology, Editor-in-Chief Dr David Henry discusses a Commentary by Dr Thomas Strouse on the use on cannabinoids in the cancer treatment setting and a Community Translations article on the recent approval of idarucizumab as the first specific oral anticoagulant reversal agent. Also included in the line-up are two Review articles, one on new therapies for antiemetic prophylaxis for chemotherapy-induced nausea and vomiting and another on the management of epidermal growth factor receptor inhibitor-associated rash; and Original Reports on cyclical hypofractionated radiotherapy for palliative treatment in locally advanced head and neck cancer and on the impact of surgery for early-stage non-small-cell lung cancer on patient quality of life.

You can listen to David Henry's JCSO podcast, January 2016 online on Radio and Podcast. Open the player on this page to stream the available audio.

David Henry's JCSO podcast, January 2016 is an episode from David Henry's JCSO Podcast by David Henry’s JCSO Podcast.

This episode is 00:07:38 long.

This episode was published on Jan 1, 2016.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from David Henry's JCSO Podcast when more episodes are available from the podcast feed.